This content is only available within our institutional offering.

03 Nov 2022
Hikma Pharmaceuticals (Buy) - 3Q trading: full year guidance reiterated; no changes

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (Buy) - 3Q trading: full year guidance reiterated; no changes
Hikma Pharmaceuticals Plc (HIK:LON) | 1,629 -456.1 (-1.7%) | Mkt Cap: 3,615m
- Published:
03 Nov 2022 -
Author:
Miles Dixon -
Pages:
5 -